Liofilchem has received clearance from the FDA to market in the United States the Piperacillin-tazobactam 0.016/4-256/4 MTS™ (MIC Test Strip), a patented quantitative assay for determining the Minimum Inhibitory Concentration (MIC) of piperacillin-tazobactam.
MTS™ TZP can be used to determine the MIC of piperacillin-tazobactam against the following microorganisms for which piperacillin-tazobactam has been shown to be active clinically and/or in vitro according to the FDA drug approved label: